Home » Topics » Regulatory » Patents

Patents
RSS

Intra-Cellular Therapies discloses PDE1B inhibitors

April 8, 2016

Jiangsu Carefree, Nanjing Carephar and Nanjing Carephar Shenghui report JAK inhibitors

April 8, 2016

Changzhou Yinsheng Pharmaceutical and Sichuan University patent HCV NS4B inhibitors

April 8, 2016

Bayer Schering Pharma divulges factor XIa inhibitors

April 8, 2016

FORMA Therapeutics develops mutant-isocitrate dehydrogenase inhibitors

April 7, 2016

Epizyme presents lysine-specific demethylase inhibitors

April 7, 2016

Ironwood Pharmaceuticals describes sGC activators

April 7, 2016

AbbVie discloses HAT inhibitors

April 7, 2016

Bayer Schering Pharma patents factor XIa and KLKB1 inhibitors

April 7, 2016

Bristol-Myers Squibb patent describes free fatty acid receptor agonists

April 6, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...